Keppra (Keppra XR, Elepsia XR) is an antiepileptic or anticonvulsant prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat seizures (epilepsy) in adults and children. It may be prescribed by itself or together with other medications to control seizures. Is there a generic for Keppra? The generic for Keppra is levetiracetam […] The post Generic Keppra (levetiracetam): Cost, coverage, and side effects appeared first on The Checkup.| The Checkup
Dexcom is a widely used continuous glucose monitoring (CGM) system. For many patients living with Type 1 or Type 2 diabetes, wearing a Dexcom can almost eliminate finger sticks (although they may still be needed occasionally). Dexcom, like other CGMs, monitors your blood glucose, or blood sugar, throughout the day and night, giving you continuous […] The post Dexcom savings guide appeared first on The Checkup.| The Checkup
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.| BioSpace
Dexcom G7 sensors can cost over $6,800 per year without insurance. Find out how to lower your costs using coupons, pharmacy comparisons, and more.| The Checkup
The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.| STAT
Drugmakers will be expected to commit to aligning U.S. prices with the lowest price set in a group of peer nations for all brand products across all markets that do not currently have generic or biosimilar competition.| BioSpace
President Trump’s executive order aimed at lowering the prices of prescription drugs in the US is unlikely to reduce them very much at all. While Trump made his announcement with great fanfare, he has little or no power to make the changes he promises. Trump’s idea, which is similar to a plan he failed to [...] The post Trump’s Plan To Tie US Drug Prices To Foreign Countries Won’t Lower Costs appeared first on Howard Gleckman.| Howard Gleckman
On average, the new Medicare negotiated drug prices are 2.8 times the average of drug prices in 11 OECD countries of similar size and wealth.| Peterson-KFF Health System Tracker
This analysis uses the Merative MarketScan 2022 commercial claims to estimate the number of enrollees in the employer-sponsored insurance market who use one or more of the ten drugs selected for Medicare Part D price negotiations.| Peterson-KFF Health System Tracker